TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function

Hou, Andrew J., Chang, ZeNan L., Lorenzini, Michael H., Zah, Eugenia, Chen, Yvonne Y.·2018·Bioengineering & Translational Medicine
DOI 10.1002/btm2.10097

Cited by (106)

Items 101–106 of 106

  1. TGF-β in tumor microenvironment, metabolism, and immunotherapy
    Haotian Bai, Yisong Y. Wan · 2024 · Elsevier eBooks
  2. Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma
    Gabrielle M. Robbins, Jae‐Woong Chang, Joshua B. Krueger, Young Y. Vue, Alexandria K. Gilkey, Timothy D. Folsom, Tyler A. Jubenville, Joseph G. Skeate, Benjamin Langworthy, Katelyn M. Fitzgerald et al. · 2025 · Molecular Therapy Oncology
  3. From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma
    Mislav Mokos, Mirna Šitum · 2026 · Journal of Personalized Medicine
  4. Le rôle des cytokines TNF-alpha et CCL2 dans l’atrophie et le dysfonctionnement thymique au cours de la leucémie aiguë myéloïde
    Meriem Ben Khoud · 2023
  5. Efficacy and synergy of low-dose radiotherapy combined with anti-PD-L1 based immunotherapy
    Pierre-Antoine Laurent · 2023
  6. A bibliometric and visualized analysis of CAR-T or TCR-T in solid tumor (from 2015 to 2024)
    Binlin Ma, Yongdong Jin · 2026 · Discover Oncology